Unknown

Dataset Information

0

Erioflorin stabilizes the tumor suppressor Pdcd4 by inhibiting its interaction with the E3-ligase ?-TrCP1.


ABSTRACT: Loss of the tumor suppressor Pdcd4 was reported for various tumor entities and proposed as a prognostic marker in tumorigenesis. We previously characterized decreased Pdcd4 protein stability in response to mitogenic stimuli, which resulted from p70(S6K1)-dependent protein phosphorylation, ?-TrCP1-mediated ubiquitination, and proteasomal destruction. Following high-throughput screening of natural product extract libraries using a luciferase-based reporter assay to monitor phosphorylation-dependent proteasomal degradation of the tumor suppressor Pdcd4, we succeeded in showing that a crude extract from Eriophyllum lanatum stabilized Pdcd4 from TPA-induced degradation. Erioflorin was identified as the active component and inhibited not only degradation of the Pdcd4-luciferase-based reporter but also of endogenous Pdcd4 at low micromolar concentrations. Mechanistically, erioflorin interfered with the interaction between the E3-ubiquitin ligase ?-TrCP1 and Pdcd4 in cell culture and in in vitro binding assays, consequently decreasing ubiquitination and degradation of Pdcd4. Interestingly, while erioflorin stabilized additional ?-TrCP-targets (such as I?B? and ?-catenin), it did not prevent the degradation of targets of other E3-ubiquitin ligases such as p21 (a Skp2-target) and HIF-1? (a pVHL-target), implying selectivity for ?-TrCP. Moreover, erioflorin inhibited the tumor-associated activity of known Pdcd4- and I?B?-regulated ?transcription factors, that is, AP-1 and NF-?B, altered cell cycle progression and suppressed proliferation of various cancer cell lines. Our studies succeeded in identifying erioflorin as a novel Pdcd4 stabilizer that inhibits the interaction of Pdcd4 with the E3-ubiquitin ligase ?-TrCP1. Inhibition of E3-ligase/target-protein interactions may offer the possibility to target degradation of specific proteins only as compared to general proteasome inhibition.

SUBMITTER: Blees JS 

PROVIDER: S-EPMC3462793 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

altmetric image

Publications


Loss of the tumor suppressor Pdcd4 was reported for various tumor entities and proposed as a prognostic marker in tumorigenesis. We previously characterized decreased Pdcd4 protein stability in response to mitogenic stimuli, which resulted from p70(S6K1)-dependent protein phosphorylation, β-TrCP1-mediated ubiquitination, and proteasomal destruction. Following high-throughput screening of natural product extract libraries using a luciferase-based reporter assay to monitor phosphorylation-dependen  ...[more]

Similar Datasets

| S-EPMC4279417 | biostudies-literature
| S-EPMC3064387 | biostudies-literature
| S-EPMC2633391 | biostudies-literature
| S-EPMC4211364 | biostudies-literature
| S-EPMC4587326 | biostudies-literature
| S-EPMC3669183 | biostudies-literature
2024-04-03 | GSE246896 | GEO
| S-EPMC8055871 | biostudies-literature
| S-EPMC6160385 | biostudies-literature
| S-EPMC4212020 | biostudies-literature